HeLa-Kyoto

Information for HeLa-Kyoto

Description

Source BRENDA Tissue Ontology (BTO)

ReMap Statistics

Datasets
8
Transcriptional Factors
2
Peaks
520,358
Non-redundant peaks
146,548

Description

Cell_name
HeLa Kyoto
Category
Cancer cell line
Disease
NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
Sex_gender_of_cell
Female
Age_of_donor
30Y6M

External IDs

Cellosaurus
CVCL_1922
Experimental Factor
BRENDA Tissue
Wiki
HeLa-Kyoto
ATCC
HeLa-Kyoto
Synonyms
HeLa 'Kyoto'; HeLa (Kyoto); HeLa isolate Kyoto; HeLa(Kyoto); HeLa-Kyoto; Hela K
All peaks HeLa-Kyoto
Download BED file
Non redundant HeLa-Kyoto
Download BED file
CRMs HeLa-Kyoto
Download BED file
DOWNLOAD All ReMap
Go to catalogue

Datasets Table for HeLa-Kyoto

Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks
HeLa Kyoto CTCF GEO Homo sapiens GSE102884 Download (47,657)
HeLa Kyoto PDS5-depleted CTCF GEO Homo sapiens GSE102884 Download (59,012)
HeLa Kyoto WAPL-depleted CTCF GEO Homo sapiens GSE102884 Download (61,010)
HeLa Kyoto WAPL_PDS-depleted CTCF GEO Homo sapiens GSE102884 Download (54,435)
HeLa Kyoto SMC3 GEO Homo sapiens GSE102884 Download (74,610)
HeLa Kyoto PDS5-depleted SMC3 GEO Homo sapiens GSE102884 Download (67,468)
HeLa Kyoto WAPL-depleted SMC3 GEO Homo sapiens GSE102884 Download (86,935)
HeLa Kyoto WAPL_PDS-depleted SMC3 GEO Homo sapiens GSE102884 Download (69,231)
Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.